৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Products
Payment
Delivery
Indications
As an adjunct to diet in adults with primary non-familial hyperlipidemia to reduce LDL-C.
Alone or with other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C.
Pharmacology
Rosuvastatin: Inhibits HMG-CoA reductase, reduces cholesterol synthesis in the liver, increases hepatic LDL receptors, enhances LDL uptake and catabolism, lowers LDL particle production.
Ezetimibe: Inhibits intestinal absorption of cholesterol via sterol transporter, reducing blood cholesterol and phytosterol uptake.
Dosage & Administration
Range: 5/10 mg to 40/10 mg orally once daily.
Severe renal impairment (not on dialysis): Start at 5/10 mg once daily; max 10/10 mg daily.
Tablets must be swallowed whole; do not crush, dissolve, or chew.
Administer ≥2 hours before or ≥4 hours after bile acid sequestrants.
Administer ≥2 hours before aluminium/magnesium hydroxide antacids.
Pediatric use: Not established.
Geriatric use: No dosage adjustment required.
Interactions
Avoid concomitant use with Cyclosporine or Gemfibrozil.
Dosage modifications required with certain antivirals, Darolutamide, Regorafenib.
Niacin, fibrates, colchicine may increase risk of myopathy/rhabdomyolysis.
Contraindications
Active liver disease or decompensated cirrhosis.
Hypersensitivity to any component.
Side Effects Common: headache, nausea, myalgia, arthralgia, dizziness, asthenia, constipation, abdominal pain, respiratory tract infection, diarrhea, sinusitis, extremity pain, fatigue, influenza, back pain.
Pregnancy & Lactation
Contraindicated in pregnancy.
Breastfeeding not recommended.
Precautions & Warnings
Myopathy/rhabdomyolysis: Risk factors include age ≥65, hypothyroidism, renal impairment, drug interactions, high dose. Discontinue if CK markedly elevated or myopathy suspected.
Hepatic dysfunction: Monitor liver enzymes before initiation and as clinically indicated. Rare cases of hepatic failure reported.
Use in Special Populations
Hepatic impairment: Contraindicated in acute liver failure or decompensated cirrhosis. Discontinue if jaundice or hyperbilirubinemia occurs.
Renal impairment: Severe impairment (CrCl <30 mL/min/1.73 m², not on dialysis): start 5/10 mg daily, max 10/10 mg. No adjustment needed for mild/moderate impairment.



Drug Class
Combination of a statin (Rosuvastatin) and a cholesterol absorption inhibitor (Ezetimibe).
Belongs to the class of lipid-lowering agents.
Purpose
Used to treat hyperlipidemia (high cholesterol).
Helps reduce LDL cholesterol (“bad cholesterol”) more effectively than either drug alone.
Prescribed to lower the risk of heart attack, stroke, and other cardiovascular diseases.
Mechanism
Rosuvastatin: Blocks HMG-CoA reductase in the liver, reducing cholesterol production.
Ezetimibe: Prevents absorption of cholesterol from the intestine.
Together, they provide dual action—less cholesterol made in the liver and less absorbed from food.
Advantages
Stronger LDL reduction: More effective than statin alone.
Convenient combination: Two medicines in one tablet reduce pill burden.
Cardiovascular protection: Helps prevent complications in patients with high cholesterol or existing heart disease.
Well tolerated: Generally safe with proper monitoring.
Dose:
Commonly available as Rosuvastatin (5–20 mg) + Ezetimibe (10 mg) tablets.
Usual dose: Once daily, taken with or without food.
Exact dosage must be prescribed by a doctor depending on cholesterol levels and patient condition.
Stronger LDL reduction: Lowers “bad cholesterol” (LDL) more effectively than statin alone.
Dual mechanism: Rosuvastatin reduces cholesterol production in the liver, while Ezetimibe blocks absorption from food.
Cardiovascular protection: Helps reduce risk of heart attack, stroke, and other complications.
Convenient combination: Two medicines in one tablet, reducing pill burden.
Improves treatment response: Useful for patients who do not reach target cholesterol levels with statin alone.
Well tolerated: Generally safe with proper monitoring of liver function and muscle health.




